University of California San Francisco

Tommaso Pollini, MD

TommasoPollini-144x192
Tommaso Pollini, MD

Postdoctoral Research Fellow

[email protected]

Biography

Dr. Tommaso Pollini, M.D. is a post-doctoral research fellow at the University of California, San Francisco (UCSF) in the Maker Lab, specializing in pancreatic cystic neoplasms with a focus on Intraductal Papillary Mucinous Neoplasms (IPMN). He completed his surgical training at the Pancreas Institute of the University of Verona, Italy, where he developed a solid foundation in pancreatic diseases. Recognized for his contributions to the field, Dr. Pollini received the prestigious Kenneth Warren Fellowship from the International Hepato-Pancreato-Biliary Association and the Steve Sotsky Award from the American Hepato-Pancreato-Biliary Association.

At UCSF, his research centers on developing predictive models for high-grade dysplasia in pancreatic cystic tumors using machine learning. Utilizing his expertise in bioinformatics, single-nucleus RNA sequencing (snRNAseq), and spatial transcriptomics, he studies the tumor immune microenvironment of pancreatic cancers. Dr. Pollini has published his work in leading journals such as JAMA Surgery, The Lancet Gastroenterology & Hepatology, and Gastroenterology, contributing significantly to advancements in pancreatic cancer research.

Education

Institution Degree Dept or School End Date
University of Verona General Surgery Residency 01/2023
University of Verona Research Fellow at the Department of General and Pancreatic Surgery of the Pancreas Institute 12/2017
University of Verona MD Medicine 10/2015

Awards & Honors

Award Conferred By Date
Kenneth Warren Fellowship International Hepato-Pancreato-Biliary Association (IHPBA) 2021/2022
Steve Sotksi Award American Hepato-Pancreato-Biliary Association (AHPBA) 2021

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 10
  1. Prevalence and Size-Based Risk Categorization of Pancreatic Cysts Among Asymptomatic Individuals With Screening MRI.
    Wong P, Pollini T, Hernandez S, Zampese M, Todeschini L, Aguilar LL, Basar SA, Hashemi S, Maker AV| | PubMed
  2. Real life management of intraductal papillary mucinous neoplasms of the pancreas: Final data from the prospective Italian pancreatic cysts (PANCY) registry.
    Crippa S, de Nucci G, Belfiori G, Pollini T, Bonamini D, Di Salvo F, Manfredi G, Alicante S, Sperti C, Moletta L, Pozza G, Manes G, Muscia R, Carrara S, Di Leo M, Zerbi A, Antonini F, Frulloni L, De Marchi G, De Petris N, Blanco GDV, Galli A, Pezzullo A, Fantin A, Stillittano D, Monica F, Germanà B, Bellini M, Cannizzaro R, Buscarini E, Falconi M| | PubMed
  3. Current Management of Intraductal Papillary Mucinous Neoplasms.
    Pollini T, Wong P, Maker AV| | PubMed
  4. 30-day postoperative mortality and the effects of hospital preparedness during the COVID-19 pandemic: a pooled analysis of prospective international cohort studies.
    NIHR Global Health Research Unit on Global Surgery| | PubMed
  5. Combination LIGHT overexpression and checkpoint blockade disrupts the tumor immune environment impacting colorectal liver metastases.
    Keenan BP, Qiao G, Kunda N, Kone L, Guldberg SM, Todeschini L, Kumar P, Pollini T, Hernandez S, Qin J, Fong L, Spitzer MH, Prabhakar BS, Maker AV| | PubMed
  6. Minimally Invasive Versus Open Resection for Solid Pseudopapillary Tumors of the Pancreas: A Propensity Score-Matched Analysis.
    Wong P, Todeschini L, Pollini T, Hernandez S, Zampese M, Aguilar LL, Peng JS, Thornblade LW, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Maker AV| | PubMed
  7. Novel Computational Analysis Identifies Cytotoxic Lymphocyte-to-Monocyte Balance in Tumors as a Predictor of Recurrence-Free Survival in Colorectal Carcinoma.
    Fernandez M, Todeschini L, Keenan BP, Rosenberg D, Hernandez S, Zampese M, Qiao G, Pollini T, Maker AV| | PubMed
  8. Impact of coronary artery stenting on perioperative mortality and complications in patients undergoing pancreaticoduodenectomy.
    Wong P, Tran TB, Pollini T, Hernandez S, Zampese M, Todeschini L, Aguilar LL, Maker VK, Maker AV| | PubMed
  9. ASO Author Reflections: Is Adjuvant Therapy Necessary for All Patients with Invasive Mucinous Cystic Neoplasms of the Pancreas? Let's De-escalate.
    Wong P, Pollini T, Maker AV| | PubMed
  10. Distinct Indications for Adjuvant Therapy in Resected Invasive Mucinous Cystic Neoplasms of the Pancreas Compared with Pancreatic Ductal Adenocarcinoma.
    Wong P, Pollini T, Adam MA, Alseidi A, Corvera CU, Hirose K, Kirkwood KS, Nakakura EK, Thornblade L, Maker AV| | PubMed